Is PRF FDA-Approved? The Answer Most Practices Get Wrong

Approval is what the FDA grants to a product for a specific use, after review of evidence that it is safe and effective for that use. Dermal fillers go through this. Drugs go through this.

Clearance is what the FDA grants to a device that is substantially equivalent to one already on the market. It attaches to the machine, not to what you do with it.

PRP and PRF preparation systems are cleared as medical devices, typically as blood cell separators. That clearance covers the device concentrating your blood. It does not cover using the result to treat hollows under your eyes or thinning at your crown.

So "prepared on an FDA-cleared system" is accurate and worth saying. "FDA-cleared for under-eye rejuvenation" is not accurate, and it is one of the most common claims on pages selling this treatment.

Using a cleared device or an approved drug for something outside its labelled indication is called off-label use. It is a routine and legal part of the practice of medicine, and a large share of what physicians do every day falls under it.

What is not permitted is promoting an off-label use as though it were an approved one. The line sits at the marketing, not at the medicine.

The honest framing, which is the one we use, is this: there is no FDA-approved indication for PRF in aesthetic treatment, its use here is off-label under the practice of medicine, and your treatment is performed in a licensed facility with a physician of record.

Here is the part that even careful practices get wrong.

Pages explaining the regulatory status of PRP and PRF very often invoke the "same surgical procedure" exception under 21 CFR 1271.15(b), the rule covering human cells and tissue products that are minimally manipulated and used in the same procedure.

The FDA's own published guidance addresses this directly and says the opposite. In its questions and answers on that exception, the agency states that platelet-rich plasma and other blood products are not considered human cells, tissues, and cellular and tissue-based products, and therefore the exception does not apply to them.

If a practice has built its regulatory explanation on that exception, the explanation is wrong even when the underlying practice is sound. The correct account rests on device clearance and on off-label use under the practice of medicine.

Because it is checkable, and because the way a practice describes its regulatory position tells you how it will describe everything else.

A practice comfortable saying "FDA-approved" about something that is not is a practice that will also be comfortable telling you results last eighteen months, that you are a candidate when you may not be, and that you should book a package today.

Precision about small things is how you predict behaviour on large ones.

Every regenerative protocol at Palm Beach Cosmetic Medicine is designed and supervised by Dr. Anna Frisch, MD, PhD, a board-certified endocrinologist, and delivered by our credentialed care team. Our PRP is prepared on an FDA-cleared concentrating system at the point of care. Neither PRP nor PRF is FDA-approved as a treatment, aesthetic use is off-label, and individual results vary.

We would rather describe the treatment accurately and let the quality of the work speak for itself.